Patent Assignment
Reel/Frame 053623/0756
Assignment of Assignor's Interest
Recorded: 2020-08-28
Pages: 7
Assignor
HEPAGENE THERAPEUTICS, INC.
Executed: 2020-07-20
Assignee
HEPAGENE THERAPEUTICS (HK) LIMITED
ROOM 2808, 28/F WU CHUNG HOUSE, 213 QUEEN'S ROAD EAST, WAN CHAI, HONG KONG
Covered Properties
(6)
Heterocyclic Containing Cyclopropyl Fxr Modulators
Nitrogen-Containing Heterocyclic Compounds As FXR Modulators
Avermectin Derivatives as Fxr Modulators
Application:
16/500,974 →
Publication:
US 2020/0031858
Dimeric Peptide Inhibitors of Apoptosis Proteins
Application:
16/633,790 →
Publication:
US 2021/0371459
Oxazole and Thiazole Derivatives as Inhibitors of ASK1
Application:
16/761,655 →
Publication:
US 2021/0179600
Urea Derivatives as Inhibitors of ASK1
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 1, 2019
From: XU, XIAODONG
To: HEPAGENE THERAPEUTICS, INC.
Reel/Frame 049055/0890 →
Assignment of Assignor's Interest
Oct 4, 2019
From: XU, XIAODONG
To: HEPAGENE THERAPEUTICS, INC.
Reel/Frame 050637/0688 →
Assignment of Assignor's Interest
Jan 24, 2020
From: XU, XIAODONG
To: HEPAGENE THERAPEUTICS, INC.
Reel/Frame 051695/0614 →
Assignment of Assignor's Interest
May 5, 2020
From: XU, XIAODONG
To: HEPAGENE THERAPEUTICS, INC.
Reel/Frame 052575/0298 →
Assignment of Assignor's Interest
May 5, 2020
From: XU, XIAODONG
To: HEPAGENE THERAPEUTICS, INC.
Reel/Frame 052578/0900 →